Cohort 1
Cohort 1 is an intervention with 9 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
6 of 6 finished
0.0%
0 ended early
3
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Identification and Description of Patients With High-risk Non Metastatic RCC
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
CD22 Redirected Autologous T Cells for ALL
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
Clinical Trials (9)
Identification and Description of Patients With High-risk Non Metastatic RCC
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
CD22 Redirected Autologous T Cells for ALL
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIV
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
Phase I Study of Safety and Immunogenicity of ADU-623
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function
All 9 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 9